Why The Morning-After Pill Is At Risk

Since the overturning of Roe v. Wade where half of US states could outlaw or reduce abortion services, more women could be turning to “Plan B,” America’s most recognized morning-after pill. Owned by two private equity firms, Kelso & Co. and Juggernaut Capital Partners, the pill is one of the highest-priced over-the-counter medications sold in the US at between $40 and $50. But confusion around the language on the label could mean trouble for the brand and its consumers.

» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision

About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.

Connect with CNBC News Online
Get the latest news: https://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC

#CNBC

Why The Morning-After Pill Is At Risk